Literature DB >> 12228920

The synthesis and study of side-chain lactam-bridged peptides.

John W Taylor1.   

Abstract

Side-chain lactam bridges linking amino acid residues that are spaced several residues apart in the linear sequence offer a convenient and flexible method for introducing conformational constraints into a peptide structure. The availability of a variety of selectively cleavable protecting groups for amines and carboxylic acids allows for several approaches to the synthesis of monocyclic, dicyclic, and bicyclic lactam-bridged peptides by solid-phase methods. Multicyclic structures are also accessible, but segment-condensation syntheses with solution-phase cyclizations are most likely to provide the best synthetic approach to these more complex constrained peptides. Lactam bridges linking (i, i + 3)-, (i, i + 4), and (i, i + 7)-spaced residue pairs have all proven useful for stabilization of alpha helices, and (i, i + 3)-linked residues have also been demonstrated to stabilize beta-turns. These structures are finding an increasing number of applications in protein biology, including studies of protein folding, protein aggregation, peptide ligand-receptor recognition, and the development of more potent peptide therapeutics. Defining the functional roles of the amphiphilic alpha-helices in medium-sized peptide hormones, and studying helix propagation from rigid, alpha-helix initiating bicyclic peptides are among the most exciting developments currently underway in this field. Copyright 2002 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 66: 49-75, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228920     DOI: 10.1002/bip.10203

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  37 in total

1.  Lactam-stabilized helical analogues of the analgesic μ-conotoxin KIIIA.

Authors:  Keith K Khoo; Michael J Wilson; Brian J Smith; Min-Min Zhang; Joszef Gulyas; Doju Yoshikami; Jean E Rivier; Grzegorz Bulaj; Raymond S Norton
Journal:  J Med Chem       Date:  2011-10-12       Impact factor: 7.446

2.  Peptide bicycles that inhibit the Grb2 SH2 domain.

Authors:  Justin S Quartararo; Pianpian Wu; Joshua A Kritzer
Journal:  Chembiochem       Date:  2012-06-11       Impact factor: 3.164

3.  Stapled peptides: Magic bullets in nature's arsenal.

Authors:  Joshua A Kritzer
Journal:  Nat Chem Biol       Date:  2010-08       Impact factor: 15.040

4.  Development of small molecules designed to modulate protein-protein interactions.

Authors:  Ye Che; Bernard R Brooks; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2006-04-19       Impact factor: 3.686

5.  The CXXC motif at the N terminus of an alpha-helical peptide.

Authors:  Teuku M Iqbalsyah; Efrosini Moutevelis; Jim Warwicker; Neil Errington; Andrew J Doig
Journal:  Protein Sci       Date:  2006-08       Impact factor: 6.725

6.  Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.

Authors:  Florence M Brunel; Michael B Zwick; Rosa M F Cardoso; Josh D Nelson; Ian A Wilson; Dennis R Burton; Philip E Dawson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Palladium Oxidative Addition Complexes for Peptide and Protein Cross-linking.

Authors:  Koji Kubota; Peng Dai; Bradley L Pentelute; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2018-02-13       Impact factor: 15.419

Review 8.  Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Authors:  Hongmei Li; Chris E Nelson; Brian C Evans; Craig L Duvall
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

9.  A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions.

Authors:  Erin E Gallagher; Arya Menon; Alyah F Chmiel; Kirsten Deprey; Joshua A Kritzer; Amanda L Garner
Journal:  Eur J Med Chem       Date:  2020-07-25       Impact factor: 6.514

10.  A two-component 'double-click' approach to peptide stapling.

Authors:  Yu Heng Lau; Yuteng Wu; Peterson de Andrade; Warren R J D Galloway; David R Spring
Journal:  Nat Protoc       Date:  2015-03-12       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.